Regentis Biomaterials Ltd (RGNT) Ownership - Who Owns Regentis Biomaterials Ltd?
Regentis Biomaterials Ltd (RGNT) Ownership Overview
- 11.23% Other Institutional Investors
- 88.77% Public Companies and Individual Investors
The ownership structure of Regentis Biomaterials Ltd (RGNT) stock is a mix of institutional, retail, and individual investors. Approximately 11.23% of the company’s stock is owned by Institutional Investors, and 88.77% is owned by Public Companies and Individual Investors.
The ownership structure of Regentis Biomaterials Ltd (RGNT) stock is a mix of institutional, retail, and individual investors. Approximately 11.23% of the company’s stock is owned by Institutional Investors, and 88.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
FAQ
What percentage of Regentis Biomaterials Ltd (RGNT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.23% of Regentis Biomaterials Ltd (RGNT) stock is held by institutional investors.
What percentage of Regentis Biomaterials Ltd (RGNT) stock is held by retail investors?
According to the latest TipRanks data, approximately 88.77% of Regentis Biomaterials Ltd (RGNT) stock is held by public companies and individual investors.
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
